리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 07월
페이지 정보:영문 382 Pages
라이선스 & 가격 (부가세 별도)
한글목차
암 치료 시설 세계 시장은 2030년까지 725억 달러에 이를 전망
2024년에 484억 달러로 추정되지만 치료 시설 세계 시장은 분석 기간인 2024-2030년 CAGR 7.0%로 성장하여 2030년에는 725억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나이지만 수술은 CAGR 7.7%를 나타내고, 분석 기간 종료까지 410억 달러에 이를 것으로 예측됩니다. 화학요법 분야의 성장률은 분석 기간을 통해서 CAGR 6.8%로 추정됩니다.
미국 시장은 132억 달러로 추정, 중국은 CAGR 11.0%로 성장 예측
미국의 암 치료 시설 시장은 2024년에 132억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 152억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 11.0%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 3.4%와 6.8%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 4.6%를 나타낼 전망입니다.
세계의 암 치료 시설 시장 - 주요 동향과 촉진요인 정리
첨단 암 치료 시설에 대한 수요가 증가하는 이유는 무엇일까?
세계적으로 암 발병률이 증가함에 따라 종합적이고 전문적인 치료를 제공하는 최첨단 암 치료 시설에 대한 수요가 증가하고 있습니다. 인구 고령화, 생활습관의 변화, 환경적 요인으로 인해 암 발생률이 증가함에 따라 의료 기관들은 최첨단 치료 기술을 갖춘 첨단 종양학 센터에 많은 투자를 하고 있습니다. 이러한 시설은 조기 진단, 정밀 치료, 다학제적 치료를 제공하여 환자의 예후를 개선하는 데 매우 중요합니다.
가치 기반 의료로의 전환도 암 치료 시설의 발전을 형성하고 있습니다. 정부와 민간 의료 서비스 제공업체들은 첨단 진단 도구, 로봇 수술, 표적 치료, 지지 요법 서비스를 암 센터에 통합하는 데 주력하고 있습니다. 또한, 양성자 치료, AI를 활용한 진단, 개인 맞춤형 의료의 부상으로 기존 치료 센터의 업그레이드 및 종양 전문 병원 신설에 대한 투자가 전 세계적으로 활발히 이루어지고 있습니다.
기술의 발전은 암 치료 센터를 어떻게 변화시키고 있는가?
암 치료 시설의 기술 통합은 환자 치료에 혁명을 일으키고 치료 효과를 높이고 있습니다. AI와 머신러닝은 현재 암의 조기 발견에 활용되고 있으며, 종양 전문의가 종양을 가장 초기에 치료할 수 있는 단계에서 종양을 식별할 수 있도록 돕고 있습니다. 또한, 양성자선 치료와 같은 정밀 방사선 치료는 암세포에 고선량의 방사선을 조사하면서 건강한 조직의 손상을 최소화하고 있습니다.
또 다른 중요한 발전은 로봇 보조 수술의 활용입니다. 로봇 보조 수술은 보다 정밀한 최소침습 수술을 가능하게 하고, 회복 시간을 단축하며, 수술 성적을 향상시킵니다. 원격의료와 디지털 헬스 플랫폼은 또한 전문 암 전문의에 대한 접근성을 확대하여, 특히 의료혜택을 충분히 받지 못하는 지역의 환자들에게 원격 진료와 세컨드 오피니언을 가능하게 하고 있습니다. 또한, 연구 주도형 암센터에서는 환자의 유전적 구성에 따라 치료 계획을 맞춤화하기 위해 유전체 시퀀싱을 통합하여 보다 효과적이고 맞춤 치료로 이어지고 있습니다.
시장 동향은 암 치료 시설 개척에 어떤 영향을 미치고 있는가?
종합적인 암 치료 모델로의 전환으로 화학요법, 방사선요법, 면역요법, 지지요법 등의 치료법을 복합적으로 제공하는 통합암센터가 설립되고 있습니다. 이러한 종합적인 접근 방식을 통해 환자들은 원활하고 협력적인 치료를 받을 수 있으며, 생존율과 삶의 질을 향상시킬 수 있습니다.
또한, 신흥 시장에서의 암 치료 시설의 확대는 큰 흐름이며, 정부 및 민간 투자자들이 아시아, 중동, 아프리카에 첨단 종양병원을 건설하고 있습니다. 전문적인 암 치료에 대한 수요가 증가함에 따라, 민관 파트너십은 의료 격차를 해소하고 세계적 수준의 암 의료 서비스에 대한 접근성을 확대하는 데 중요한 역할을 하고 있습니다. 또한, 웰빙, 편안함, 정신 건강 지원에 중점을 둔 환자 중심의 설계 원칙이 최신 암센터에 적용되어 전반적인 치료 경험을 향상시키고 있습니다.
시장의 주요 성장 촉진요인은 무엇인가?
암 치료 시설 시장의 성장 원동력은 암 발병률 증가, 급속한 기술 발전, 전문적인 암 치료의 필요성입니다. AI, 로봇공학, 정밀의료에 대한 투자로 치료 성과를 높이고 최신 암센터의 역량을 확장하고 있습니다. 가치에 기반한 헬스케어의 추진과 전인적 치료 접근법의 통합도 시장 확대에 기여하고 있습니다.
또한, 종양학 인프라에 대한 정부 자금과 민간 투자는 특히 신흥 경제국에서 새로운 암 치료 센터의 개발을 가속화하고 있습니다. 원격 의료와 디지털 종양학 서비스의 등장은 환자의 전문가 치료에 대한 접근성을 더욱 변화시키고 있으며, 원격지에 거주하는 사람들도 첨단 암 치료의 혜택을 누릴 수 있도록 하고 있습니다. 암 연구와 치료법이 계속 발전하고 있는 가운데, 조사기법 시장은 앞으로도 지속적인 성장이 예상됩니다.
부문
치료 유형(암 수술, 화학요법, 방사선 요법, 호르몬 요법, 기타 치료 유형), 암 유형(혈액암, 유방암, 전립선암, 소화기 암, 부인과 암, 호흡기/폐암, 기타 암 유형), 제공업체(병원, 암 치료 센터)
조사 대상 기업 예
Asan Medical Center
Charite-Universitatsmedizin Berlin
Cleveland Clinic
Dana-Farber Cancer Institute
Gustave Roussy
Hospital of the University of Pennsylvania
Hospital Universitari Vall d'Hebron
Institut Curie
Johns Hopkins Hospital
Mayo Clinic
MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Center Hospital
Peter MacCallum Cancer Centre
Samsung Medical Center
Seoul National University Hospital
Singapore General Hospital
The Royal Marsden NHS Foundation Trust
University Hospital Heidelberg
University of Michigan Hospitals-Michigan Medicine
AI 통합
Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.
Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.
관세 영향 계수
Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
LSH
영문 목차
영문목차
Global Cancer Treatment Facilities Market to Reach US$72.5 Billion by 2030
The global market for Cancer Treatment Facilities estimated at US$48.4 Billion in the year 2024, is expected to reach US$72.5 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Cancer Surgery, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$41.0 Billion by the end of the analysis period. Growth in the Chemotherapy segment is estimated at 6.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$13.2 Billion While China is Forecast to Grow at 11.0% CAGR
The Cancer Treatment Facilities market in the U.S. is estimated at US$13.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$15.2 Billion by the year 2030 trailing a CAGR of 11.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.
Global Cancer Treatment Facilities Market - Key Trends & Drivers Summarized
Why Is the Demand for Advanced Cancer Treatment Facilities Growing?
The increasing global burden of cancer has led to a heightened demand for state-of-the-art cancer treatment facilities that offer comprehensive and specialized care. With cancer rates rising due to aging populations, lifestyle changes, and environmental factors, healthcare institutions are investing heavily in advanced oncology centers equipped with cutting-edge treatment technologies. These facilities are crucial in delivering early diagnosis, precision treatments, and multidisciplinary care to improve patient outcomes.
The transition toward value-based healthcare is also shaping the development of cancer treatment facilities. Governments and private healthcare providers are focusing on integrating advanced diagnostic tools, robotic surgeries, targeted therapies, and supportive care services into cancer centers. Additionally, the rise of proton therapy, AI-driven diagnostics, and personalized medicine has fueled investments in upgrading existing treatment centers and building new specialized oncology hospitals worldwide.
How Are Technological Advancements Transforming Cancer Treatment Centers?
The integration of technology in cancer treatment facilities is revolutionizing patient care and enhancing treatment efficacy. AI and machine learning are now being used for early cancer detection, enabling oncologists to identify tumors at their earliest and most treatable stages. Moreover, precision radiation therapy, such as proton beam therapy, is minimizing damage to healthy tissues while delivering high-dose radiation to cancer cells.
Another key advancement is the use of robotic-assisted surgeries, which allow for minimally invasive procedures with higher precision, reducing recovery time and improving surgical outcomes. Telemedicine and digital health platforms are also expanding access to expert oncologists, enabling remote consultations and second opinions, particularly for patients in underserved regions. Additionally, research-driven cancer centers are integrating genomic sequencing to customize treatment plans based on a patient’s genetic makeup, leading to more effective and personalized therapies.
How Are Market Trends Impacting Cancer Treatment Facility Development?
The shift toward comprehensive cancer care models has led to the establishment of integrated cancer centers that offer a combination of treatment modalities, including chemotherapy, radiation, immunotherapy, and supportive care. This holistic approach ensures that patients receive seamless and coordinated care, improving survival rates and quality of life.
Additionally, the expansion of cancer treatment facilities in emerging markets is a major trend, with governments and private investors building advanced oncology hospitals in Asia, the Middle East, and Africa. As demand for specialized cancer care grows, public-private partnerships are playing a key role in bridging healthcare gaps and expanding access to world-class oncology services. Moreover, patient-centric design principles are being incorporated into modern cancer centers, with a focus on wellness, comfort, and mental health support to improve the overall treatment experience.
What Are the Key Growth Drivers in the Market?
The growth in the cancer treatment facilities market is driven by increasing cancer prevalence, rapid technological advancements, and the need for specialized oncology care. Investments in AI, robotics, and precision medicine are enhancing treatment outcomes and expanding the capabilities of modern cancer centers. The push for value-based healthcare and the integration of holistic treatment approaches are also contributing to the market’s expansion.
Furthermore, government funding and private investments in oncology infrastructure are accelerating the development of new cancer treatment centers, particularly in emerging economies. The rise of telemedicine and digital oncology services is further transforming patient access to expert care, ensuring that even remote populations can benefit from advanced cancer treatments. As cancer research and treatment methodologies continue to evolve, the cancer treatment facilities market is expected to experience sustained growth in the coming years.
SCOPE OF STUDY:
The report analyzes the Cancer Treatment Facilities market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Treatment Type (Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy, Other Treatment Types); Cancer Type (Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynecologic Cancer, Respiratory/Lung Cancer, Other Cancer Types); Provider (Hospitals, Cancer Treatment Centers)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 34 Featured) -
Asan Medical Center
Charite - Universitatsmedizin Berlin
Cleveland Clinic
Dana-Farber Cancer Institute
Gustave Roussy
Hospital of the University of Pennsylvania
Hospital Universitari Vall d'Hebron
Institut Curie
Johns Hopkins Hospital
Mayo Clinic
MD Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Center Hospital
Peter MacCallum Cancer Centre
Samsung Medical Center
Seoul National University Hospital
Singapore General Hospital
The Royal Marsden NHS Foundation Trust
University Hospital Heidelberg
University of Michigan Hospitals-Michigan Medicine
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Cancer Treatment Facilities - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Global Cancer Incidence Driving Demand for Advanced Treatment Facilities
Expansion of Multidisciplinary Cancer Care Centers Enhancing Patient Outcomes
Increased Investment in Oncology Infrastructure in Emerging Economies
Growing Focus on Outpatient and Ambulatory Cancer Treatment Centers
Integration of Advanced Imaging and Radiation Therapy Equipment in Modern Facilities
Shift Toward Personalized and Genomic-Based Treatment Protocols
Rise of Comprehensive Cancer Hospitals Offering End-to-End Services
Growing Role of Tele-Oncology and Remote Treatment Platforms
Adoption of AI and Big Data for Treatment Planning and Facility Management
Increased Public-Private Partnerships in Oncology Care Infrastructure
Expansion of Daycare Chemotherapy and Immunotherapy Services
Wider Access to Proton and Heavy Ion Therapy at Specialized Facilities
Growing Focus on Palliative Care and Support Services in Cancer Centers
Hospital Accreditation and Certification Trends Supporting Quality Enhancement
Integration of Electronic Health Records and Oncology Information Systems Improving Workflow
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Cancer Treatment Facilities Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Cancer Treatment Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 4: World 15-Year Perspective for Cancer Treatment Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Cancer Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 7: World 15-Year Perspective for Cancer Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 10: World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 13: World 15-Year Perspective for Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Hormone Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Hormone Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 16: World 15-Year Perspective for Hormone Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 19: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Gynecologic Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Gynecologic Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 22: World 15-Year Perspective for Gynecologic Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Respiratory / Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Respiratory / Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 25: World 15-Year Perspective for Respiratory / Lung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 28: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Blood Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Blood Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 31: World 15-Year Perspective for Blood Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 34: World 15-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 37: World 15-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Gastrointestinal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 39: World Historic Review for Gastrointestinal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 40: World 15-Year Perspective for Gastrointestinal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 41: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 42: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 43: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
TABLE 44: World Recent Past, Current & Future Analysis for Cancer Treatment Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 45: World Historic Review for Cancer Treatment Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 46: World 15-Year Perspective for Cancer Treatment Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 47: USA Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 48: USA Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 49: USA 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 50: USA Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 51: USA Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 52: USA 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 53: USA Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 54: USA Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 55: USA 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
CANADA
TABLE 56: Canada Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 58: Canada 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 59: Canada Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 60: Canada Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 61: Canada 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 62: Canada Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 63: Canada Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 64: Canada 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
JAPAN
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 65: Japan Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 66: Japan Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 67: Japan 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 68: Japan Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 69: Japan Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 70: Japan 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 71: Japan Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 72: Japan Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 73: Japan 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
CHINA
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 74: China Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 75: China Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 76: China 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 77: China Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 78: China Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 79: China 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 80: China Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 81: China Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 82: China 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
EUROPE
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 83: Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Cancer Treatment Facilities by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 85: Europe 15-Year Perspective for Cancer Treatment Facilities by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
TABLE 86: Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 87: Europe Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 88: Europe 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 89: Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 90: Europe Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 91: Europe 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 92: Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 93: Europe Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 94: Europe 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
FRANCE
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 95: France Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 96: France Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 97: France 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 98: France Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 99: France Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 100: France 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 101: France Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 102: France Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 103: France 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
GERMANY
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 104: Germany Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 105: Germany Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 106: Germany 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 107: Germany Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 108: Germany Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 109: Germany 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 110: Germany Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 111: Germany Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 112: Germany 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
ITALY
TABLE 113: Italy Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 114: Italy Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 115: Italy 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 116: Italy Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 117: Italy Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 118: Italy 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 119: Italy Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 120: Italy Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 121: Italy 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
UNITED KINGDOM
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 122: UK Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 123: UK Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 124: UK 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 125: UK Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 126: UK Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 127: UK 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 128: UK Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 129: UK Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 130: UK 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
SPAIN
TABLE 131: Spain Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 132: Spain Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 133: Spain 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 134: Spain Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 135: Spain Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 136: Spain 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 137: Spain Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 138: Spain Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 139: Spain 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
RUSSIA
TABLE 140: Russia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 141: Russia Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 142: Russia 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 143: Russia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 144: Russia Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 145: Russia 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 146: Russia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 147: Russia Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 148: Russia 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
REST OF EUROPE
TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 150: Rest of Europe Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 151: Rest of Europe 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 153: Rest of Europe Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 154: Rest of Europe 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 156: Rest of Europe Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 157: Rest of Europe 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
ASIA-PACIFIC
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 159: Asia-Pacific Historic Review for Cancer Treatment Facilities by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 160: Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 162: Asia-Pacific Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 163: Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 165: Asia-Pacific Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 166: Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 168: Asia-Pacific Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 169: Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
AUSTRALIA
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
TABLE 170: Australia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 171: Australia Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 172: Australia 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 173: Australia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 174: Australia Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 175: Australia 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 176: Australia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 177: Australia Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 178: Australia 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
INDIA
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
TABLE 179: India Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 180: India Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 181: India 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 182: India Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 183: India Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 184: India 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 185: India Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 186: India Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 187: India 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
SOUTH KOREA
TABLE 188: South Korea Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 189: South Korea Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 190: South Korea 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 191: South Korea Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 192: South Korea Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 193: South Korea 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 194: South Korea Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 195: South Korea Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 196: South Korea 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
REST OF ASIA-PACIFIC
TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 198: Rest of Asia-Pacific Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 201: Rest of Asia-Pacific Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 204: Rest of Asia-Pacific Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
LATIN AMERICA
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
TABLE 206: Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 207: Latin America Historic Review for Cancer Treatment Facilities by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 208: Latin America 15-Year Perspective for Cancer Treatment Facilities by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
TABLE 209: Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 210: Latin America Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 211: Latin America 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 212: Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 213: Latin America Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 214: Latin America 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 215: Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 216: Latin America Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 217: Latin America 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
ARGENTINA
TABLE 218: Argentina Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 219: Argentina Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 220: Argentina 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 221: Argentina Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 222: Argentina Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 223: Argentina 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 224: Argentina Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 225: Argentina Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 226: Argentina 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
BRAZIL
TABLE 227: Brazil Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 228: Brazil Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 229: Brazil 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 230: Brazil Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 231: Brazil Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 232: Brazil 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 233: Brazil Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 234: Brazil Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 235: Brazil 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
MEXICO
TABLE 236: Mexico Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 237: Mexico Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 238: Mexico 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 239: Mexico Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 240: Mexico Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 241: Mexico 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 242: Mexico Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 243: Mexico Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 244: Mexico 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
REST OF LATIN AMERICA
TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 246: Rest of Latin America Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 247: Rest of Latin America 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 249: Rest of Latin America Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 250: Rest of Latin America 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 252: Rest of Latin America Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 253: Rest of Latin America 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
MIDDLE EAST
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
TABLE 254: Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
TABLE 255: Middle East Historic Review for Cancer Treatment Facilities by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 256: Middle East 15-Year Perspective for Cancer Treatment Facilities by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
TABLE 257: Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 258: Middle East Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 259: Middle East 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 260: Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 261: Middle East Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 262: Middle East 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 263: Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 264: Middle East Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 265: Middle East 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
IRAN
TABLE 266: Iran Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 267: Iran Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 268: Iran 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 269: Iran Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 270: Iran Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 271: Iran 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 272: Iran Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 273: Iran Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 274: Iran 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
ISRAEL
TABLE 275: Israel Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 276: Israel Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 277: Israel 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 278: Israel Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 279: Israel Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 280: Israel 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 281: Israel Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 282: Israel Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 283: Israel 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
SAUDI ARABIA
TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 285: Saudi Arabia Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 286: Saudi Arabia 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 288: Saudi Arabia Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 289: Saudi Arabia 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 291: Saudi Arabia Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 292: Saudi Arabia 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
UNITED ARAB EMIRATES
TABLE 293: UAE Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 294: UAE Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 295: UAE 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 296: UAE Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 297: UAE Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 298: UAE 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 299: UAE Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 300: UAE Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 301: UAE 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
REST OF MIDDLE EAST
TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 303: Rest of Middle East Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 304: Rest of Middle East 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 306: Rest of Middle East Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 307: Rest of Middle East 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 309: Rest of Middle East Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 310: Rest of Middle East 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030
AFRICA
Cancer Treatment Facilities Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
TABLE 311: Africa Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 312: Africa Historic Review for Cancer Treatment Facilities by Treatment Type - Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 313: Africa 15-Year Perspective for Cancer Treatment Facilities by Treatment Type - Percentage Breakdown of Value Sales for Cancer Surgery, Chemotherapy, Radiation Therapy, Hormone Therapy and Other Treatment Types for the Years 2015, 2025 & 2030
TABLE 314: Africa Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 315: Africa Historic Review for Cancer Treatment Facilities by Cancer Type - Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 316: Africa 15-Year Perspective for Cancer Treatment Facilities by Cancer Type - Percentage Breakdown of Value Sales for Gynecologic Cancer, Respiratory / Lung Cancer, Other Cancer Types, Blood Cancer, Breast Cancer, Prostate Cancer and Gastrointestinal Cancer for the Years 2015, 2025 & 2030
TABLE 317: Africa Recent Past, Current & Future Analysis for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
TABLE 318: Africa Historic Review for Cancer Treatment Facilities by Provider - Hospitals and Cancer Treatment Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
TABLE 319: Africa 15-Year Perspective for Cancer Treatment Facilities by Provider - Percentage Breakdown of Value Sales for Hospitals and Cancer Treatment Centers for the Years 2015, 2025 & 2030